BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/24/2021 2:29:50 AM | Browse: 348 | Download: 677
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 66988
Country/Territory China
Received
2021-04-19 14:49
Peer-Review Started
2021-04-19 14:52
To Make the First Decision
Return for Revision
2021-06-14 06:36
Revised
2021-06-27 15:05
Second Decision
2021-12-02 03:26
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-12-03 06:57
Articles in Press
2021-12-03 06:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-11-26 00:48
Typeset the Manuscript
2021-12-16 10:11
Publish the Manuscript Online
2021-12-24 02:29
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Neoadjuvant treatment strategies for hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Lei Xu, Lin Chen and Wei Zhang
ORCID
Author(s) ORCID Number
Lei Xu http://orcid.org/0000-0001-9942-648X
Lin Chen http://orcid.org/0000-0002-0190-7769
Wei Zhang http://orcid.org/0000-0002-3380-1010
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81860117
Corresponding Author Wei Zhang, MD, Assistant Professor, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jie Fang Avenue, Wuhan 430030, Hubei Province, China. weizhangtjh@hust.edu.cn
Key Words Hepatocellular carcinoma; Neoadjuvant therapy; Prognosis; Indications; Contraindications
Core Tip Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. A considerable number of patients cannot receive radical therapy due to advanced HCC at the first diagnosis, leading to a poor prognosis. Neoadjuvant treatment enables more patients with HCC inside or outside the Milan criteria to receive surgical treatment, such as partial liver resection and liver transplantation. In this study, we reviewed the current status of neoadjuvant therapy in HCC.
Publish Date 2021-12-24 02:29
Citation Xu L, Chen L, Zhang W. Neoadjuvant treatment strategies for hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(12): 1550-1566
URL https://www.wjgnet.com/1948-9366/full/v13/i12/1550.htm
DOI https://dx.doi.org/10.4240/wjgs.v13.i12.1550
Full Article (PDF) WJGS-13-1550.pdf
Full Article (Word) WJGS-13-1550.docx
Manuscript File 66988_Auto_Edited-JLW-Filipodia.docx
Answering Reviewers 66988-Answering reviewers.pdf
Audio Core Tip 66988-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 66988-Conflict-of-interest statement.pdf
Copyright License Agreement 66988-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 66988-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 66988-Language certificate.pdf
Peer-review Report 66988-Peer-review(s).pdf
Scientific Editor Work List 66988-Scientific editor work list.pdf